Astria Therapeutics, Inc. (ATXS) Misses Q3 EPS by 14c
Tweet
Share
E-mailGet Alerts ATXS Hot Sheet
Join SI Premium – FREE
Astria Therapeutics, Inc. (NASDAQ: ATXS) reported Q3 EPS of ($0.63), $0.14 worse than the analyst estimate of ($0.49).
For earnings history and earnings-related data on Astria Therapeutics, Inc. (ATXS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Benchmark Reiterates Buy Rating on H World Group Ltd. (HTHT) Following Q2 Print
- Cummins wins battery storage contract for U.S. data center project
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
